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The Crystal Structure of 
Monovalent Streptavidin
Min Zhang1,2, Sangita Biswas2, Wenbin Deng2 & Hongjun Yu3
The strong interaction between streptavidin (SA) and biotin is widely utilized in biotechnological 
applications. A SA variant, monovalent SA, was developed with a single and high affinity biotin-binding 
site within the intact tetramer. However, its structural characterization remains undetermined. Here, 
we seek to determine the crystal structure of monovalent SA at 1.7-Å resolution. We show that, in 
contrast to its ‘close-state’ in the only wild-type subunit, the L3,4 loops of three Dead SA subunits are 
free from crystal packing and remain in an ‘open state’, stabilized by a consistent H-bonding network 
involving S52. This H-bonding network also applies to the previously reported open state of the wild-
type apo-SA. These results suggest that specific substitutions (N23A/S27D/S45A) at biotin-binding 
sites stabilize the open state of SA L3,4 loop, thereby further reducing biotin-binding affinity. The 
general features of the ‘open state’ SA among different SA variants may facilitate its rational design. 
The structural information of monovalent SA will be valuable for its applications across a wide range of 
biotechnological areas.
Streptavidin (SA) is a tetrameric protein derived from the bacterium Streptomyces Avidini, which exhibits extraor-
dinary affinity for biotin1,2. The streptavidin-biotin system is acknowledged as one of the most stable noncovalent 
interactions and has wide applications in the field of biotechnology such as molecular-labeling, molecular- local-
ization and targeted drug delivery3,4.
Recognizing the utility of this system in different applications, extensive engineering efforts have been made 
to modify the SA system. For example, to reduce the immunogenicity of SA in clinical use, a low immuno-
genic SA mutant has been designed and structurally investigated5,6. Similarly, despite the high affinity of 
biotin-streptavidin, biotin dissociation results from low endosomal pH7 or being attached to nanoparticles8. This 
issue was overcome by traptavidin, a SA variant bearing S52G/R53D mutants9, which was also explained later by 
its crystal structural10. Moreover, four biotin-binding sites of SA tetramer can multimerize biotinylated ligands, 
affecting their function or causing target aggregation11. Howarth et al.12 reported the production of monovalent 
streptavidin with N23A/S27D/S45A triple mutants in three Dead subunits. This chimeric SA variant has a single 
biotin-binding site with high (femtomolar) affinity and is still in tetramer form. However, the information regard-
ing the structural basis of its function is still missing.
In this study, we report the 1.65 Å crystal structure of monovalent SA with three Dead subunits containing 
N23A/S27D/S45A triple mutants. In this structure, the L3,4 loops of three Dead subunits, all adopted open con-
formation in contrast to the close conformation of the only wild type subunit in the same SA tetramer. A consist-
ent H-bonding network was found to stabilize the open L3,4 among three Dead subunits, which involves S52 on 
the L3,4 loop. This H-bonding network also applies to the apo-SA with open L3,4 and may be a general feature 
of the open conformation of SA. These results suggest that the substitutions at biotin-binding sites (N23A/S27D/
S45A) may stabilize the open conformation of the L3,4 loop, and further reduce biotin-binding. These insights 
from monovalent SA structure promote our understanding of this widely used biotechnological system and can 
facilitate its rational modification and application.
Results
Overview of monovalent streptavidin structure. Monovalent streptavidin structure was determined 
at 1.65 Å by molecular replacement using wild-type SA tetramer (PDB id: 3RY1) as the search model. It was 
with P1 space group (Table 1), containing a tetramer in the asymmetric unit. Each subunit is composed of an 
eight-stranded antiparallel β -barrel (Fig. 1a), typical of SA structures previously reported13. To identify the only 
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wild-type SA subunit (WT subunit) from the other three inactive subunits (Dead subunits with N23A/S27D/
S45A triple mutations), the side chains at residue 23 and 27 of wild-type SA (PDB id: 3RY1) were removed 
and used for molecular replacement. After solving the phase, an unbiased map at reside 23 and 27 was subse-
quently generated to identify the missing side chain (Methods and Fig. 1b). By this analysis, the chain A, B and 
C were identified as Dead subunits and chain D was identified as wild-type one (WT subunit). Notably, density 
around residue 45 was not included for this analysis because it locates to the L3,4 loop, which exhibited variable 
conformations.
Different conformations of L3,4 loop between wild type and Dead subunits. The biotin binding 
sites are located at one end of these β -barrels (Fig. 1a). L3,4 (residues 45–52) the loop connecting β -strands 3 and 4, 
exhibited different conformations among four subunits (Fig. 1a). The L3,4 loop is usually flexible in apo-SA, 
adopting either ‘open’ or ‘close’ conformation while it always folds over bound biotin (in ‘close’ conformation)10,13. 
To investigate the different conformations of L3,4 in monovalent SA, we then compared its four subunits with 
apo-SA open conformation (chain D of pdb id: 3RY1, referred as ‘apo-open conformation’ in later description), 
and biotin-bound ‘close’ conformation (chain A of pdb id: 1MK5, referred as ‘biotin-close conformation’ in later 
description). This revealed that WT subunit (chain D) resembles the biotin-close conformation while three Dead 
subunits (chain A, B and C) are comparable to the apo-open conformation (Fig. 2 and Supplementary Table 1). 
The conformation of the L3,4 loop made the main difference between these two forms. This loop bends over the 
biotin site in the WT subunit (chain D). However, in all three Dead subunits (chain A, B and C), the L3,4 loops 
remain open, exposing their ligand binding sites (Fig. 3a). Calculation of electron density near this loop region 
suggested the reliable tracing of main chain in four subunits, though the density was relatively weak in chain A 
(Fig. 3b).
The ‘open’ L3,4 loops are consistently stabilized in all Dead streptavidin subunits. Loops 
between streptavidin β -strands are often involved in crystal packing13. We therefore evaluated the crystal packing 
around the L3,4 loop in monovalent SA structure. As a result, for the only WT subunit (chain D), there is only one 
H-bond between S52 main chain at the base of L3,4, and T66 main chain from L4,5 loop of neighboring subunit, 
which may favor the ‘close’ conformation of its L3,4 over ‘open’ conformation (Supplementary Fig. 1d and e). 
However, L3,4 loops within three Dead subunits (chain A, B and C) are free from crystal packing (Supplementary 
Fig. 1a-c), which enabled us to evaluate direct effects of mutations on L3,4. As we discussed above, L3,4 of all three 
Monovalent SA
Data collection
Space group P1
Cell dimensions  
 a, b, c (Å) 44.36, 56.74, 57.43
 α , β , γ  (°) 87.54, 85.89, 67.99
 Resolution (Å) 50-1.65 (1.74–1.65)
 Rsym or Rmerge (%) 6.8 (45.8)
 I/σ I 9.8 (2.5)
 Completeness (%) 94.8 (93.6)
 Redundancy 3.3 (3.3)
Refinement
Resolution (Å) 50.0–1.65
No. reflections 62294
Rwork/Rfree 20.0/23.3
No. atoms 3907
 Protein 3618
 Water 282
 PEG 7
B-factors 25.7
 Protein 24.9
 Water 35.5
 PEG 49.5
R.m.s. deviations
 Bond lengths (Å) 0.010
 Bond angles (°) 1.42
Ramachandran plot (%)
 Preferred 96.1
 Allowed 3.7
 Outlier 0.2
Table 1.  Data collection and structure refinement statistics of monovalent streptavidin.
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Figure 1. Structure of monovalent streptavidin. (a) Structure of the monovalent streptavidin, with the three 
Dead subunits (chain A, B and C) represented by in blue, cyan and magenta color respectively, and the WT 
subunit (chain D) in yellow. (b) Unbiased electron densities at mutation sites 23 and 27 were generated with 
their side chains deleted before molecular replacement and determining their identities. Grey mesh, 2fo-fc map 
contoured at 1.1 sigma; green mesh, fo-fc map contoured at 3 sigma.
Figure 2. Cα deviations after structural alignment of the four subunits (chain A–D in this study) with two 
previously reported conformations of SA. (a) Comparison with biotin-close conformation (chain A of pdb 
id: 1MK5). (b) Comparison with apo-open conformation (chain D of pdb id: 3RY1). The curves are colored 
identical to the subunit colors in Fig. 1.
www.nature.com/scientificreports/
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subunits are consistently open (Fig. 3a). Furthermore, we observed an universal H-bonding network is responsi-
ble for stabilizing this open L3,4 conformation in all three Dead subunits: S27D side chain forms a H-bond with 
main chain of A46; S52 side chain interacts with main chains of N49 (chain A, B and C) and V47 (chain A only) 
Figure 3. Different L3,4 conformations between Dead and WT SA subunits. (a) Four monovalent SA 
subunits (chain A–D, colored identical to that seen in Fig. 1) were superposed with two previously known 
SA states: biotin-close conformation (dark green, chain A of pdb id: 1MK5), and the apo-open conformation 
(orange, chain D of pdb id: 3RY1). (b–e) electron densities (grey mesh, 2fo-fc map contoured at 1.1 sigma) 
around the L3,4 of four monovalent SA subunits.
www.nature.com/scientificreports/
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(Fig. 4a–c); S52 main chain form a H-bond with S45A main chain. Notably, in previously reported wild-type 
apo-open conformation, we found similar H-bonding interactions within open L3,4, that is, S52 side chain forms 
H-bonds with N49 main chain and S45 main chain (Fig. 4e). In contrast, in the close L3,4 observed in WT subu-
nit (chain D), these interactions cannot be maintained because S52 rotates almost 180° (Fig. 4d). These results in 
different SA variants indicated the important role of S52 in stabilizing the open conformation of L3,4.
In the WT subunit, one PEG molecule take up the space which biotin tail occupies and forms a H-bond with 
the N49 main chain, similar to biotin binding (Fig. 4d). Therefore, the biotin-binding site of WT subunit closely 
resembles that observed in the biotin-bound state. Further superimposition of these different subunits revealed 
that S27D mutation may generate steric hindrance with A46 in close L3,4 (Fig. 4f), suggesting this may result in 
the shift of this loop and form a preferred open conformation maintained by S52.
Discussion
By solving the structure of monovalent streptavidin, we found substantial conformational changes between 
the single wild-type subunit and three Dead subunits, localized to their L3,4 loops. Specifically, L3,4 loop folds 
over the biotin-binding site in WT subunit while it remains in ‘open’ conformation among three Dead subunits 
(Fig. 3a). The L3,4 loops free from crystal packing (Supplementary Fig. 1) enabled us to evaluate the effects of 
N23A/S27D/S45A mutations on biotin binding (Fig. 4). We found that S27D may sterically force the L3,4 to shift 
away from biotin-binding site and stabilize its open conformation through an H-bonding network involving S52 
(Fig. 4f). It was proposed that N23A/S27D/S45A directly attenuated the binding of biotin12,14. Here our analysis 
suggest the stabilized open L3,4 caused by these mutants may further reduce the binding of biotin, because only 
close L3,4 can provide extra sites for biotin-binding (Fig. 4f). Moreover, these stabilized open L3,4 loops may 
also expose the biotin binding site, resulting in fast release of biotin. Consistently, the open L3,4 was previously 
proposed to explain the fast dissociation of ALiS from SA15. All these effects together may account for the sub-
stantial reduction of biotin binding to N23A/S27D/S45A mutants12. Our results also suggested the important role 
of S52 in stabilizing the open conformation of L3,4, the ‘lid’ of the biotin-binding pocket. This involves H-bonds 
between S52, N49 and S45 (or A45 if mutated), which was observed in all three Dead subunits in this study, and 
also in apo-open wild-type SA (Fig. 4). Previous studies indicated that SA S52G caused reduction of on-rate and 
off-rate binding constants for ligand binding, and SA structures having S52G mutants all exhibited closed L3,4 
lid, regardless of the presence or absence of ligand10,16. Based on our analysis, these effects of S52G are probably 
caused by the collapse of the H-bonding network within the open L3,4 and the subsequent destabilization of this 
open conformation. These insights emphasized the H-bonds within the open L3,4 loop in biotin-binding kinetics, 
which can be potential target for modulating SA properties to overcome its disadvantages such as non-favored 
ligand dissociation7,8.
Materials and Methods
Monovalent streptavidin expression and purification. The monovalent streptavidin in tetrameric 
form was generated as previously described12. Briefly, wild-type SA (with His8-tag) and Dead (N23A/S27D/
S45A) SA (without His8-tag) were expressed in E. coli BL21 (DE3) cells as inclusion bodies. The collected cells 
were lysed by sonication and the inclusion bodies were isolated and washed twice with washing buffer (20 mM 
Tris–HCl, pH 8.0, 0.3 M NaCl, 2 M urea) to reach over 80% purity. The purified inclusion bodies pellet of wild-
type and mutant streptavidin were both resuspended in solubilization buffer (20 mM Tris–HCl, pH 8.0, 0.3 M 
NaCl, 8 M urea) and then were centrifuged at 15,000 rpm for 30 min to remove insoluble material. After deter-
mining the concentration by OD280 (NanoDrop 2000, Thermo Scientific), the solubilized inclusion bodies of 
wild-type and mutated streptavidin were mixed in 1:3 ratio. The mixture was then fast diluted (drop by drop) 
into PBS buffer (10 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl) for the refolding of streptavidin tetramer. 
Ammonium sulfated gradient precipitation was performed to remove the partially folded streptavidin and some 
contaminant protein12,17. Different forms of the SA tetramer were separated through a step gradient elution on 
Nickel charged-nitrilotriacetic acid (Ni-NTA, Qiagen) affinity chromatography and monovalent streptavidin 
was eluted in buffer with 100 mM imidazole as previously described18. The sample was then incubated with the 
Proteinase K at the weight ration of 100:1 for 5hr at 20 °C to remove the only his-tag on wild-type SA subunit18. 
The protease-treated sample was further purified through size exclusion chromatography (Superdex 75 column) 
with Tris-sodium buffer (20 mM Tris-HCl, pH 8.0, 150 mM NaCl) to remove the protease and to achieve more 
homogeneous state. The purified, tag-free monovalent SA tetramer was concentrated to 10–15 mg/ml and was 
frozen and stored at − 80 °C.
Crystallization of monovalent streptavidin protein. Crystal screens were set up using commercial 
screens (Hampton Research) by the hanging drop vapor diffusion methods in 96-well plates at 20 °C, where the 
drops are mixtures of 0.5 ul of well solution and 0.5 ul protein sample (10 mg/ml, Tris-sodium buffer). Crystals 
were obtained against a reservoir solution containing 0.1 M Tris pH 8.3, 0.25 M MgCl2 and 32% poly ethylene 
glycol (PEG) 4K. Crystals were then picked and flash-frozen in liquid nitrogen. The diffraction data was collected 
at BL17U beamline at Shanghai Synchrotron Radiation Facility (SSRF).
Structural determination. Diffraction data was processed and scaled using Mosflm19. To solve the phase 
and to identify the only wild-type subunit, we used apo-SA tetramer (PDB id: 3RY1) as the search model with all 
the side chains at mutated sites 23, 27 being deleted. The molecular replacement was performed with MOLREP20 
(a program for automated molecular replacement where a homologous structure has already been identified) 
followed by one round of automatic refinement with REFMAC21 in CCP419. The fo-fc and 2fo-fc maps at this stage 
were then carefully analyzed to assign the wild-type and Dead subunits and to build the missing side chains. 
After that, several round of refinement with REFMAC (a program designed for REFinement of MACromolecular 
www.nature.com/scientificreports/
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structures) and model adjustment with COOT22 (Crystallographic Object-Oriented Toolkit) was performed. 
Waters were added to the models at the last stage. The statistics for data collection and refinement were summa-
rized in Table 1. Structural figures were made using a molecular graphics and modelling package (PyMOL)23.
Figure 4. Effects of N23A/S27D/S45 mutations. Different subunits are colored identical to that seen in Fig. 3a. 
(a–c) A universal H-bonding network to stabilize the open L3,4 of Dead subunits with N23A/S27D/S45 triple 
mutants. H-bonds are indicated by dashed lines. (d) Comparison between WT subunit (yellow) and biotin-close 
conformation (dark green, chain A of pdb id: 1MK5). A PEG molecule was identified in the ligand-binding site 
of WT subunit, which involves an H-bond with N49 main chain (black dashed lines). The H-bonds observed in 
Dead subunits (panel a–c) can’t be maintained due to conformational change of L3,4. (e) H-bonding network 
(black dashed lines) observed in apo-open conformation (chain D of pdb id: 3RY1) is comparable to that in 
Dead subunits (panel a–c). (f) Comparison of the L3,4 loop and biotin-binding pocket among the 4 subunit 
structures (panel (a–d) in monovalent streptavidin identified the effects of N23A/S27D/S45A in Dead subunits. 
N23A/S27D/S45A can directly damage the interaction with biotin while S27D mutation may cause shift of L3,4 
away from biotin-site into a stabilized open state, further reducing biotin interaction otherwise provided by 
close L3,4 loop. Curve dash line indicates the effects of S27D mutation. The change of L3,4 loop from open to 
close conformation is indicated by four arrows. Biotin (dark green stick) was modeled as shown in panel (d).
www.nature.com/scientificreports/
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